| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 15/12/21 | GSK | 07:00:02 | 15 Dec 2021 | | GSK | GSK/Sanofi COVID-19 vaccine booster & Ph3 update | GlaxoSmithKline PLC | RNS |
| 13/12/21 | GSK | 11:25:08 | 13 Dec 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/12/21 | GSK | 16:35:46 | 9 Dec 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/12/21 | GSK | 12:00:09 | 7 Dec 2021 | | GSK | Medicago/GSK COVID-19 vaccine positive Ph3 data | GlaxoSmithKline PLC | RNS |
| 07/12/21 | GSK | 07:07:28 | 7 Dec 2021 | | GSK | Sotrovimab retains its activity vs Omicron variant | GlaxoSmithKline PLC | RNS |
| 02/12/21 | GSK | 07:02:05 | 2 Dec 2021 | | GSK | Sotrovimab retains its activity vs Omicron variant | GlaxoSmithKline PLC | RNS |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 24/11/21 | GSK | 16:17:43 | 24 Nov 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/11/21 | GSK | 16:00:09 | 24 Nov 2021 | | GSK | GSK publishes provisional 2022 dividend dates | GlaxoSmithKline PLC | RNS |
| 23/11/21 | GSK | 15:06:44 | 23 Nov 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/11/21 | GSK | 07:00:06 | 17 Nov 2021 | | GSK | Nucala approved in Europe for more indications | GlaxoSmithKline PLC | RNS |
| 15/11/21 | GSK | 16:37:51 | 15 Nov 2021 | | GSK | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 12/11/21 | GSK | 12:00:03 | 12 Nov 2021 | | GSK | Phase III IM administration data for sotrovimab | GlaxoSmithKline PLC | RNS |
| 12/11/21 | GSK | 09:23:55 | 12 Nov 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/11/21 | GSK | 11:28:50 | 10 Nov 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/11/21 | GSK | 17:33:01 | 5 Nov 2021 | | GSK | GSK shares positive Phase III data for daprodustat | GlaxoSmithKline PLC | RNS |
| 01/11/21 | GSK | 17:11:05 | 1 Nov 2021 | | GSK | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 27/10/21 | GSK | 14:23:48 | 27 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 27/10/21 | GSK | 12:00:00 | 27 Oct 2021 | | GSK | 3rd Quarter Results | GlaxoSmithKline PLC | RNS |
| 27/10/21 | GSK | 09:00:01 | 27 Oct 2021 | | GSK | Directorate Change | GlaxoSmithKline PLC | RNS |
| 15/10/21 | GSK | 14:41:05 | 15 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/21 | GSK | 16:31:08 | 14 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/21 | GSK | 16:28:15 | 14 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/21 | GSK | 13:55:23 | 13 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/21 | GSK | 15:17:56 | 12 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/21 | GSK | 13:36:19 | 12 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/21 | GSK | 13:33:36 | 12 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/21 | GSK | 13:30:42 | 12 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/10/21 | GSK | 13:28:02 | 12 Oct 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/10/21 | GSK | 11:54:37 | 1 Oct 2021 | | GSK | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 24/09/21 | GSK | 17:28:28 | 24 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 22/09/21 | GSK | 15:58:02 | 22 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/09/21 | GSK | 14:42:16 | 20 Sept 2021 | | GSK | Director Declaration | GlaxoSmithKline PLC | RNS |
| 13/09/21 | GSK | 17:26:22 | 13 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/09/21 | GSK | 16:42:22 | 9 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/09/21 | GSK | 16:54:06 | 7 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/09/21 | GSK | 09:32:19 | 3 Sept 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/09/21 | GSK | 11:44:39 | 1 Sept 2021 | | GSK | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 31/08/21 | GSK | 07:00:11 | 31 Aug 2021 | | GSK | SK bio & GSK start Ph3 Covid-19 vaccine trial | GlaxoSmithKline PLC | RNS |
| 25/08/21 | GSK | 14:01:31 | 25 Aug 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 23/08/21 | GSK | 16:39:56 | 23 Aug 2021 | | GSK | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/08/21 | | 09:38:47 | 13 Aug 2021 | | | Director/PDMR Shareholding - amendment | GlaxoSmithKline PLC | RNS |
| 11/08/21 | | 14:18:34 | 11 Aug 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/08/21 | | 12:34:40 | 11 Aug 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/08/21 | | 09:00:02 | 5 Aug 2021 | | | Block Listing Application | GlaxoSmithKline PLC | RNS |
| 02/08/21 | | 14:23:31 | 2 Aug 2021 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 28/07/21 | | 17:32:32 | 28 Jul 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/07/21 | | 12:00:01 | 28 Jul 2021 | | | 2nd Quarter Results | GlaxoSmithKline PLC | RNS |